Can a supplement ease arthritis pain in IBD patients?
NCT ID NCT07447154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a dietary supplement called GenesiDol for managing muscle and joint pain in people with inflammatory bowel disease (IBD), like Crohn's disease or ulcerative colitis. About 40 adults with persistent pain will take the supplement for 8 weeks to see if it reduces pain and improves quality of life. The goal is to find a safer option than long-term painkillers or immune-suppressing drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can we predict how kids with IBD will respond to treatment?
- Can group learning make biotherapy safer for arthritis patients?
- Gentle tai chi may get spondyloarthritis patients moving
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?